Verona Pharma (NASDAQ:VRNA – Free Report) had its price target hoisted by Canaccord Genuity Group from $44.00 to $72.00 in a research note published on Wednesday,Benzinga reports. They currently have ...
The company’s diversification across wealth management, asset management, and insurance muddies the company’s financials, and investors might discount the company’s valuation because of this.
The persistent rise in US equities is helping promote a view that the relationships of old for stocks and traditional measures for value-oriented investing strategies no longer apply.
PG&E downgrades to Underweight at Morgan Stanley, joining California utility peer Edison International with the bank's ...
The era of ultralow interest rates fostered a leveraged buyout boom and a desperate hunger for yield among investors. The ...
Race, national origin, and other non-financial considerations should never play a role in determining how much home equity ... of home equity you can use is lower than the amount you have in theory.
Fourth quarter net income of $1.21 per diluted share and adjusted operating income of $1.25 per diluted share; full year net income of $2.39 per diluted share and adjusted operating income of $2.56 pe ...
StockNews.com downgraded shares of Loews (NYSE:L – Free Report) from a buy rating to a hold rating in a research note published on Tuesday morning. Loews Stock Down 1.2 % Shares of NYSE L opened at ...
The MetLife Holdings segment consists of products that are no longer actively sold in the US and profits from this segment should continue to decrease. The firm also operates with strong market ...
U.S. President Donald Trump ’s mercurial approach to his signature tariffs whipsawed markets last week. And investors trying to position their equity portfolios to manage this ongoing uncertainty are ...
What hasn’t changed is Trump’s strategy of pledging aggressive levies on trading partners and then quickly backtracking, ...
Millrose Properties and Lennar Corporation started regular-way trading. MRP opened at $23.49, made an intraday high of $27.07 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results